Published in Infect Immun on December 01, 2002
IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol (2012) 2.03
Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig Dis Sci (2004) 1.51
In vivo imaging and genetic analysis link bacterial motility and symbiosis in the zebrafish gut. Proc Natl Acad Sci U S A (2007) 1.40
Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations. PLoS One (2014) 1.39
The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev (2014) 1.34
Utility of serological markers in inflammatory bowel diseases: gadget or magic? World J Gastroenterol (2007) 1.32
Biomarkers in inflammatory bowel disease: current practices and recent advances. Transl Res (2012) 1.29
The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol (2011) 1.27
Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol (2004) 1.26
Microbiology, genomics, and clinical significance of the Pseudomonas fluorescens species complex, an unappreciated colonizer of humans. Clin Microbiol Rev (2014) 1.10
Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand. Immunogenetics (2009) 1.00
Identification and characterisation of Pseudomonas 16S ribosomal DNA from ileal biopsies of children with Crohn's disease. PLoS One (2008) 0.95
The clinical Pseudomonas fluorescens MFN1032 strain exerts a cytotoxic effect on epithelial intestinal cells and induces Interleukin-8 via the AP-1 signaling pathway. BMC Microbiol (2010) 0.94
The arable ecosystem as battleground for emergence of new human pathogens. Front Microbiol (2014) 0.94
Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis. Gut (2006) 0.91
Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease. Inflamm Bowel Dis (2009) 0.89
Metagenomic analysis of the pygmy loris fecal microbiome reveals unique functional capacity related to metabolism of aromatic compounds. PLoS One (2013) 0.88
Serological markers of inflammatory bowel disease. Biochem Med (Zagreb) (2013) 0.83
Pseudomonas fluorescens-like bacteria from the stomach: a microbiological and molecular study. World J Gastroenterol (2013) 0.82
Pseudomonas fluorescens alters epithelial permeability and translocates across Caco-2/TC7 intestinal cells. Gut Pathog (2010) 0.82
Laboratory markers in ulcerative colitis: Current insights and future advances. World J Gastrointest Pathophysiol (2015) 0.81
Crohn's disease and infections: a complex relationship. MedGenMed (2004) 0.80
Acute ileitis facilitates infection with multidrug resistant Pseudomonas aeruginosa in human microbiota-associated mice. Gut Pathog (2017) 0.79
RahU: an inducible and functionally pleiotropic protein in Pseudomonas aeruginosa modulates innate immunity and inflammation in host cells. Cell Immunol (2011) 0.79
Involvement of epidermal growth factor receptor-linked signaling responses in Pseudomonas fluorescens-infected alveolar epithelial cells. Infect Immun (2011) 0.78
Cytotoxicity and inflammatory potential of two Pseudomonas mosselii strains isolated from clinical samples of hospitalized patients. BMC Microbiol (2013) 0.77
Possible diagnostic role of antibodies to Crohn's disease peptide (ACP): results of a multicenter study in a Japanese cohort. J Gastroenterol (2013) 0.76
Isolation and characterization of a novel short peptide associated with Crohn's disease. Clin Exp Immunol (2011) 0.76
Metagenomic analysis of the Rhinopithecus bieti fecal microbiome reveals a broad diversity of bacterial and glycoside hydrolase profiles related to lignocellulose degradation. BMC Genomics (2015) 0.76
Comparative genomics of Pseudomonas fluorescens subclade III strains from human lungs. BMC Genomics (2015) 0.76
Pfit is a structurally novel Crohn's disease-associated superantigen. PLoS Pathog (2013) 0.75
Increased Enterococcus faecalis infection is associated with clinically active Crohn disease. Medicine (Baltimore) (2016) 0.75
Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease. World J Gastrointest Pharmacol Ther (2016) 0.75
Identification of bacterial infection in neotropical primates. Microb Ecol (2013) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature (2000) 32.30
Mucosal flora in inflammatory bowel disease. Gastroenterology (2002) 8.42
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86
Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest (1996) 4.59
Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology (2000) 3.90
Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun (1998) 3.80
Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol (1999) 2.92
Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut (2000) 2.71
Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol (1997) 2.55
Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology (1995) 2.47
The structural basis of T cell activation by superantigens. Annu Rev Immunol (1999) 2.34
Conjugative transposition. Annu Rev Microbiol (1995) 2.30
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun (2001) 1.94
Interaction of pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs. Proc Natl Acad Sci U S A (2000) 1.81
Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology (1984) 1.79
The Crohn's disease-associated bacterial protein I2 is a novel enteric t cell superantigen. Immunity (2001) 1.69
Fecal microbial flora in Seventh Day Adventist populations and control subjects. Am J Clin Nutr (1977) 1.65
Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology (2000) 1.64
Specific detection of Mycobacterium paratuberculosis by DNA hybridisation with a fragment of the insertion element IS900. Gut (1991) 1.63
Derangement of mucosal barrier function by bacteria colonizing the rat colonic mucosa. Eur J Clin Invest (1998) 1.60
Subversion of the immune system by pathogens. Cell (1994) 1.53
Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev (1999) 1.52
Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun (2000) 1.49
Lack of support for a common etiology in Johne's disease of animals and Crohn's disease in humans. Inflamm Bowel Dis (1999) 1.49
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. J Antimicrob Chemother (1997) 1.44
An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol (1996) 1.44
Functional analysis of PvdS, an iron starvation sigma factor of Pseudomonas aeruginosa. J Bacteriol (2000) 1.40
Selected bacterial antibodies in Crohn's disease and ulcerative colitis. Scand J Gastroenterol (1983) 1.37
Outbreak of Pseudomonas fluorescens bacteremia among oncology patients. J Clin Microbiol (1998) 1.37
Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect Immun (2000) 1.33
Cell wall-defective variants of pseudomonas-like (group Va) bacteria in Crohn's disease. Gastroenterology (1978) 1.30
Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease. Infect Immun (1999) 1.28
The role of the fecal stream in Crohn's disease: an historical and analytic review. Inflamm Bowel Dis (1998) 1.19
Pseudomonas infections in patients with AIDS and AIDS-related complex. J Intern Med (1992) 1.16
Analysis of promoters recognized by PvdS, an extracytoplasmic-function sigma factor protein from Pseudomonas aeruginosa. J Bacteriol (2001) 1.14
Mucosal immunity and inflammation. II. The yin and yang of T cells in intestinal inflammation: pathogenic and protective roles in a mouse colitis model. Am J Physiol (1999) 1.13
Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis. Vet Microbiol (2000) 1.08
Clinical role for a superantigen in Yersinia pseudotuberculosis infection. J Clin Invest (1997) 1.05
The oxygen- and iron-dependent sigma factor pvdS of Pseudomonas aeruginosa is an important virulence factor in experimental infective endocarditis. J Infect Dis (2000) 1.01
DNA hybridization studies of the association of Pseudomonas maltophilia with inflammatory bowel diseases. J Lab Clin Med (1983) 1.00
Phylogenetic placement of community members of human colonic biota. Clin Infect Dis (1997) 0.98
Pseudomonas aeruginosa exoenzyme S induces transcriptional expression of proinflammatory cytokines and chemokines. Infect Immun (2000) 0.91
Memory/effector T cells in TCR transgenic mice develop via recognition of enteric antigens by a second, endogenous TCR. Int Immunol (1999) 0.89
Transcriptional regulation of the iron-responsive sigma factor gene pbrA. Mol Gen Genet (1996) 0.88
Serum antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease. Dig Dis Sci (1999) 0.84
T-cell transfer and cytokine/TCR gene deletion models in the study of inflammatory bowel disease. APMIS (1997) 0.83
Endotoxic shock after transfusion of contaminated red blood cells in a child with sickle cell disease. Pediatr Infect Dis J (1991) 0.81
Defining new pathogens and nonculturable infectious agents associated with inflammatory bowel disease. Curr Opin Gastroenterol (2000) 0.77
FSH directly regulates bone mass. Cell (2006) 4.64
Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med (2007) 3.27
Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology (2002) 3.21
Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair (Amst) (2003) 2.52
TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol (2007) 2.17
Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology (2012) 2.11
Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest (2011) 2.09
TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology (2008) 2.06
Intestinal mucosal inflammation leads to systemic genotoxicity in mice. Cancer Res (2009) 1.90
TNFalpha blockade in human diseases: an overview of efficacy and safety. Clin Immunol (2007) 1.85
Abundant and diverse fungal microbiota in the murine intestine. Appl Environ Microbiol (2006) 1.76
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res (2005) 1.74
Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci U S A (2005) 1.71
A model for harmonizing flow cytometry in clinical trials. Nat Immunol (2010) 1.70
Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci U S A (2003) 1.60
A system for sharing routine surgical pathology specimens across institutions: the Shared Pathology Informatics Network. Hum Pathol (2007) 1.59
Diagnosis of coccidioidomycosis by antigen detection using cross-reaction with a Histoplasma antigen. Clin Infect Dis (2007) 1.49
Early microbial markers of celiac disease. J Clin Gastroenterol (2014) 1.48
CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. PLoS One (2011) 1.44
Commensal microbiota and CD8+ T cells shape the formation of invariant NKT cells. J Immunol (2010) 1.43
Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol Rev (2004) 1.34
B cell developmental requirement for the G alpha i2 gene. J Immunol (2003) 1.31
Quantitation of cell number by a positron emission tomography reporter gene strategy. Mol Imaging Biol (2004) 1.26
Escherichia coli strains (ndk) lacking nucleoside diphosphate kinase are powerful mutators for base substitutions and frameshifts in mismatch-repair-deficient strains. Genetics (2002) 1.25
Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samples. Clin Cancer Res (2008) 1.25
Systemic control of plasmacytoid dendritic cells by CD8+ T cells and commensal microbiota. J Immunol (2008) 1.24
Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resist Updat (2004) 1.22
Bacteria associated with immunoregulatory cells in mice. Appl Environ Microbiol (2009) 1.18
Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome. Cancer (2006) 1.18
The tetraspan protein epithelial membrane protein-2 interacts with beta1 integrins and regulates adhesion. J Biol Chem (2002) 1.16
Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol (2006) 1.14
TCR-mediated hyper-responsiveness of autoimmune Galphai2(-/-) mice is an intrinsic naïve CD4(+) T cell disorder selective for the Galphai2 subunit. Int Immunol (2003) 1.13
The tetraspan protein EMP2 modulates the surface expression of caveolins and glycosylphosphatidyl inositol-linked proteins. Mol Biol Cell (2004) 1.13
Epithelial membrane protein-2 regulates surface expression of alphavbeta3 integrin in the endometrium. Dev Biol (2005) 1.12
A metaproteomic approach to study human-microbial ecosystems at the mucosal luminal interface. PLoS One (2011) 1.12
Epithelial membrane protein-2 is expressed in discrete anatomical regions of the eye. Exp Mol Pathol (2003) 1.12
Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res (2004) 1.10
Monitoring the antitumor response of naive and memory CD8 T cells in RAG1-/- mice by positron-emission tomography. J Immunol (2006) 1.09
Commensal microbiota alter the abundance and TCR responsiveness of splenic naïve CD4+ T lymphocytes. Clin Immunol (2005) 1.09
Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution. Pediatrics (2005) 1.09
FAK activation and the role of epithelial membrane protein 2 (EMP2) in collagen gel contraction. Invest Ophthalmol Vis Sci (2008) 1.06
A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. PLoS One (2013) 1.06
Formation of B and T cell subsets require the cannabinoid receptor CB2. Immunogenetics (2006) 1.05
Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay. Clin Infect Dis (2008) 1.05
Knockdown of the tetraspan protein epithelial membrane protein-2 inhibits implantation in the mouse. Dev Biol (2006) 1.04
The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell death. Clin Immunol (2003) 1.04
Collagen gel contraction by ARPE-19 cells is mediated by a FAK-Src dependent pathway. Exp Eye Res (2007) 1.03
The phonemic restoration effect reveals pre-N400 effect of supportive sentence context in speech perception. Brain Res (2010) 1.01
The tetraspan protein EMP2 regulates expression of caveolin-1. J Biol Chem (2007) 0.99
Resident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cells. Eur J Immunol (2008) 0.99
Molecular imaging of murine intestinal inflammation with 2-deoxy-2-[18F]fluoro-D-glucose and positron emission tomography. Gastroenterology (2008) 0.99
Competition between MutY and mismatch repair at A x C mispairs In vivo. J Bacteriol (2003) 0.97
Host-microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interface. Inflamm Bowel Dis (2011) 0.97
Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer. Clin Lung Cancer (2005) 0.95
Serological responses to microbial antigens in celiac disease patients during a gluten-free diet. J Clin Immunol (2008) 0.95
Acanthamoeba keratitis: the persistence of cases following a multistate outbreak. Ophthalmic Epidemiol (2012) 0.94
Steroid hormone regulation of EMP2 expression and localization in the endometrium. Reprod Biol Endocrinol (2008) 0.93
Spherical lactic acid bacteria activate plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells. PLoS One (2012) 0.93
Epithelial membrane protein 2 modulates infectivity of Chlamydia muridarum (MoPn). Microbes Infect (2007) 0.91
IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression. Biochem Biophys Res Commun (2005) 0.91
Phytoestrogens as cardioprotective agents. Cardiol Rev (2004) 0.91
Surveillance B lymphocytes and mucosal immunoregulation. Springer Semin Immunopathol (2004) 0.91
Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP. Int J Cancer (2008) 0.90
Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines. Clin Cancer Res (2008) 0.90
Intestinal bacteria modify lymphoma incidence and latency by affecting systemic inflammatory state, oxidative stress, and leukocyte genotoxicity. Cancer Res (2013) 0.90
Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development. Cancer (2010) 0.90
Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease. J Clin Immunol (2008) 0.90
Constitutive neuronal expression of the immune regulator, programmed death 1 (PD-1), identified during experimental autoimmune uveitis. Ocul Immunol Inflamm (2009) 0.89
Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer. Clin Cancer Res (2010) 0.89
Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease. Inflamm Bowel Dis (2009) 0.89
Functional consequences of interactions between FAK and epithelial membrane protein 2 (EMP2). Invest Ophthalmol Vis Sci (2009) 0.89
Phenotype of Pseudomonas aeruginosa isolates causing corneal infection between 1997 and 2000. Cornea (2003) 0.89
Epithelial membrane protein-2 promotes endometrial tumor formation through activation of FAK and Src. PLoS One (2011) 0.89
Developing a genetic system in Deinococcus radiodurans for analyzing mutations. Genetics (2004) 0.88
Intestinal inflammation induces genotoxicity to extraintestinal tissues and cell types in mice. Int J Cancer (2011) 0.87
Colitis immunoregulation by CD8+ T cell requires T cell cytotoxicity and B cell peptide antigen presentation. Am J Physiol Gastrointest Liver Physiol (2008) 0.86
Integration of B cells and CD8+ T in the protective regulation of systemic epithelial inflammation. Clin Immunol (2008) 0.86
Transmission of mycobacterium tuberculosis via lung transplantation. Am J Transplant (2004) 0.86
Elevated serum anti-I2 and anti-OmpW antibody levels in children with IBD. Inflamm Bowel Dis (2006) 0.86
Epithelial uptake of [18F]1-(2'-deoxy-2'-arabinofuranosyl) cytosine indicates intestinal inflammation in mice. Gastroenterology (2010) 0.85
Villous B cells of the small intestine are specialized for invariant NK T cell dependence. J Immunol (2008) 0.85
Blockade of epithelial membrane protein 2 (EMP2) abrogates infection of Chlamydia muridarum murine genital infection model. FEMS Immunol Med Microbiol (2009) 0.85
Small intestine CD11c+ CD8+ T cells suppress CD4+ T cell-induced immune colitis. Am J Physiol Gastrointest Liver Physiol (2011) 0.85
BetaB1-crystallin: identification of a candidate ciliary body uveitis antigen. Invest Ophthalmol Vis Sci (2003) 0.84
Recombinant carcinoembryonic antigen as a reporter gene for molecular imaging. Eur J Nucl Med Mol Imaging (2008) 0.83
Atherogenic diet causes lethal ileo-ceco-colitis in cyclooxygenase-2 deficient mice. Prostaglandins Other Lipid Mediat (2007) 0.83
Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer. Mol Cancer Ther (2014) 0.83
Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments. Mol Imaging Biol (2013) 0.82
Current understanding of fungal microflora in inflammatory bowel disease pathogenesis. Inflamm Bowel Dis (2008) 0.82
Role of the immune modulator programmed cell death-1 during development and apoptosis of mouse retinal ganglion cells. Invest Ophthalmol Vis Sci (2009) 0.81
CCFA microbial-host interactions workshop: highlights and key observations. Inflamm Bowel Dis (2007) 0.81
Sampling of intestinal microbiota and targeted amplification of bacterial 16S rRNA genes for microbial ecologic analysis. Curr Protoc Immunol (2014) 0.81
The role of tumour necrosis factor-α and tumour necrosis factor receptor signalling in inflammation-associated systemic genotoxicity. Mutagenesis (2011) 0.81
Anti-EMP2 diabody blocks epithelial membrane protein 2 (EMP2) and FAK mediated collagen gel contraction in ARPE-19 cells. Exp Eye Res (2012) 0.80
Genetics, Genetic Testing, and Biomarkers of Digestive Diseases. Gastroenterology (2015) 0.80
Peripheral myelin protein-22 (PMP22) modulates alpha 6 integrin expression in the human endometrium. Reprod Biol Endocrinol (2011) 0.80
One-step RT-PCR for screening microdissected tissue samples. Biotechniques (2002) 0.79
Epithelial membrane protein 2 controls VEGF expression in ARPE-19 cells. Invest Ophthalmol Vis Sci (2013) 0.79